Developer docs
API playgroundTry for free, no card

Search company profiles

Evogene

Full company profile

uuid002g7uu

Namestring
Evogene
Websiteurl
evogene.com
Company typeenum
Private
Founded yearint
2002
Descriptiontext

Evogene is a computational biology company headquartered in Rehovot, Israel, founded in 1999. According to its own short_description, the firm "utilizes computational biology technologies to revolutionize life-science product development," indicating its core function is the application of computational methods to discovery, design, or optimization within life-science value chains (e.g., ag-bio, therapeutics, or industrial biotechnology are plausible but unconfirmed by the source material).

The company's underlying technology stack, platform architecture, proprietary algorithms, and product portfolio were not extractable from the available source material. The primary website extraction (evogene.com) returned only a loading placeholder ("One moment, please... Loader... Please wait while your request is being verified"), and no products_and_services, technology, ai_capability_types, or patents_and_trademarks fields were populated. Firmographic data indicates a headcount band of 101-250 employees, consistent with a mid-sized R&D-oriented organization rather than an early-stage startup.

Evogene's business model, pricing structure, go-to-market motion, customer segments, named accounts, and partnership network are not documented in the available data. No revenue figures, funding rounds, leadership team, M&A activity, or regulatory actions were captured. This absence represents a material information gap: any investment thesis on revenue mechanics, customer concentration, unit economics, or commercialization stage cannot be grounded in the supplied evidence and must be deferred until primary disclosures are obtained.

Short descriptiontext

Evogene is a Rehovot, Israel-based computational biology company founded in 1999 that applies computational technologies to life-science product development. The firm employs 101-250 staff; specific products, customers, and revenue details were not extractable from the available sources.

Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersRehovot, Israel
HQ citystring
Rehovot
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Keyword5 values
computational biology, life-science development, biology technology platforms, biotech R&D, computational life sciences
Industry3 codes
PRIMARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAAAIAD
Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAAAIAC
Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
NAICS code3 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Prepackaged Software7372
Product category
Computational Biology Platforms
Social media profiles1 record
Cost components2 values
Technology or R&D, Personnel
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Evogene applies computational biology technologies to support and accelerate life-science product development. The company uses computational tools to revolutionize how life-science products are discovered and developed by its customers.

Differentiator
Functional benefit
Problem solved
Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Peers10 records
1Zymergen (now part of Ginkgo Bioworks)
TypeBroad incumbent
Description

Developed a platform combining biology, automation, and machine learning to engineer microbes for industrial applications. Comparable to Evogene's synthetic-biology/AI platform orientation.

TypeDirect peer
Description

Israel-based genomics and AI company providing computational solutions for plant breeding and life-science research. Comparable to Evogene by geography, technology, and agricultural biology focus.

TypeDirect peer
Description

Applies machine learning and high-throughput biology to drug discovery. Comparable to Evogene's AI/ML platform approach to life-science product development.

TypeEmerging player
Description

Applies gene editing and computational biology to develop improved crops. Comparable to Evogene as an emerging AI/computational-biology player in agricultural life sciences.

TypeDirect peer
Description

Uses AI, high-throughput biology, and automated experimentation to discover and develop drug candidates. Comparable to Evogene as an AI/ML-driven life-science discovery company with a platform model.

TypeEmerging player
Description

Uses AI for small-molecule drug discovery. Comparable to Evogene as an AI/ML-driven life-science discovery company, though focused on chemistry-based rather than biological-product discovery.

TypeDirect peer
Description

Provides a computational platform combining physics-based modeling and machine learning for drug discovery and materials design. Comparable to Evogene as a software/AI-driven life-science discovery platform sold to R&D organizations.

TypeDirect peer
Description

Uses AI/ML-driven genomics and crop analytics to develop plant-based food and ingredient products. Comparable to Evogene as an AI/biology platform targeting agricultural and food applications.

TypeDirect peer
Description

Applies AI and predictive design to seed development for sustainable agriculture. Comparable to Evogene's agricultural applications of its computational biology platform.

TypeDirect peer
Description

Operates a platform applying synthetic biology, AI, and high-throughput screening to engineer organisms for industrial, agricultural, and pharmaceutical customers. Closely comparable to Evogene's computational biology platform serving multiple life-science verticals.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Evogene

Computational Biology Platformsevogene.com

Evogene is a Rehovot, Israel-based computational biology company founded in 1999 that applies computational technologies to life-science product development. The firm employs 101-250 staff; specific products, customers, and revenue details were not extractable from the available sources.

What Evogene does

Evogene is a computational biology company headquartered in Rehovot, Israel, founded in 1999. According to its own short_description, the firm "utilizes computational biology technologies to revolutionize life-science product development," indicating its core function is the application of computational methods to discovery, design, or optimization within life-science value chains (e.g., ag-bio, therapeutics, or industrial biotechnology are plausible but unconfirmed by the source material).

The company's underlying technology stack, platform architecture, proprietary algorithms, and product portfolio were not extractable from the available source material. The primary website extraction (evogene.com) returned only a loading placeholder ("One moment, please... Loader... Please wait while your request is being verified"), and no products_and_services, technology, ai_capability_types, or patents_and_trademarks fields were populated. Firmographic data indicates a headcount band of 101-250 employees, consistent with a mid-sized R&D-oriented organization rather than an early-stage startup.

Evogene's business model, pricing structure, go-to-market motion, customer segments, named accounts, and partnership network are not documented in the available data. No revenue figures, funding rounds, leadership team, M&A activity, or regulatory actions were captured. This absence represents a material information gap: any investment thesis on revenue mechanics, customer concentration, unit economics, or commercialization stage cannot be grounded in the supplied evidence and must be deferred until primary disclosures are obtained.

Evogene firmographics

Firmographics
Name
Evogene
Website
https://evogene.com
Company type
Private
Founded year
2002
Headcount range
51–100 employees
Short description
Evogene is a Rehovot, Israel-based computational biology company founded in 1999 that applies computational technologies to life-science product development. The firm employs 101-250 staff; specific products, customers, and revenue details were not extractable from the available sources.
Ownership category
akta.pro rank

Evogene industry classification

Industry
Product category
Computational Biology Platforms
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171), Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAAAIAD
Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAAAIAC
Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)

Keywords

  • Computational biology
  • Life-science development
  • Biology technology platforms
  • Biotech R&D
  • Computational life sciences

Where Evogene is headquartered

Location

Headquarters

HQ city
Rehovot
HQ country
Israel
HQ region
Middle East

Markets served

Evogene business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel

Evogene product offering

Product offering

Core offering

Evogene applies computational biology technologies to support and accelerate life-science product development. The company uses computational tools to revolutionize how life-science products are discovered and developed by its customers.

Differentiator

Problem solved

Functional benefit

Companies that use Evogene

Customer profile

Ideal customer profiles1 record

Evogene technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Evogene partnerships and signals

Strategic signal

Recent moves1 record

Evogene competitors and assessment

Company assessment

Broad incumbents

  • Zymergen (now part of Ginkgo Bioworks): Developed a platform combining biology, automation, and machine learning to engineer microbes for industrial applications. Comparable to Evogene's synthetic-biology/AI platform orientation.

Direct peers

  • NRGene: Israel-based genomics and AI company providing computational solutions for plant breeding and life-science research. Comparable to Evogene by geography, technology, and agricultural biology focus.
  • Insitro: Applies machine learning and high-throughput biology to drug discovery. Comparable to Evogene's AI/ML platform approach to life-science product development.
  • Recursion Pharmaceuticals: Uses AI, high-throughput biology, and automated experimentation to discover and develop drug candidates. Comparable to Evogene as an AI/ML-driven life-science discovery company with a platform model.
  • Schrödinger, Inc. Provides a computational platform combining physics-based modeling and machine learning for drug discovery and materials design. Comparable to Evogene as a software/AI-driven life-science discovery platform sold to R&D organizations.
  • Benson Hill: Uses AI/ML-driven genomics and crop analytics to develop plant-based food and ingredient products. Comparable to Evogene as an AI/biology platform targeting agricultural and food applications.
  • Inari Agriculture: Applies AI and predictive design to seed development for sustainable agriculture. Comparable to Evogene's agricultural applications of its computational biology platform.
  • Ginkgo Bioworks: Operates a platform applying synthetic biology, AI, and high-throughput screening to engineer organisms for industrial, agricultural, and pharmaceutical customers. Closely comparable to Evogene's computational biology platform serving multiple life-science verticals.

Emerging players

  • Pairwise: Applies gene editing and computational biology to develop improved crops. Comparable to Evogene as an emerging AI/computational-biology player in agricultural life sciences.
  • Atomwise: Uses AI for small-molecule drug discovery. Comparable to Evogene as an AI/ML-driven life-science discovery company, though focused on chemistry-based rather than biological-product discovery.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat3 records

Key risks4 records

Key highlights4 records

Customer concentration

Evogene social profiles

Digital presence

Evogene financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Evogene leadership team

Management profile

Number of profiles

Evogene funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Evogene M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Evogene

What does Evogene do?

Evogene applies computational biology technologies to support and accelerate life-science product development. The company uses computational tools to revolutionize how life-science products are discovered and developed by its customers.

When was Evogene founded?

Evogene was founded in 2002. It employs 51 to 100 people.

Where is Evogene based?

Evogene is headquartered in Rehovot, Israel, in the Middle East region.

Who are Evogene's main competitors?

Zymergen (now part of Ginkgo Bioworks) is listed as a broad incumbent. Direct peers are NRGene, Insitro, Recursion Pharmaceuticals, Schrödinger, Inc., Benson Hill, Inari Agriculture and Ginkgo Bioworks. Emerging players are Pairwise and Atomwise.

Does Evogene have an API?

No public API is recorded for Evogene.

What industry is Evogene in?

Evogene's product category is Computational Biology Platforms. Its primary akta.pro industry code is HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization, with a secondary code of HLAAAIAD, Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MorningstarLeading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of Highly Qualified Director NomineesEvogene Ltd. announced that ISS and Glass Lewis recommended shareholders vote FOR its director nominees at the September 4, 2026 Annual General Meeting. The firms also supported all other proposals, citing the dissidents' lack of a compelling case for change. The company urged shareholders to disregard the Pure Capital nominees.PR NewswireEvogene Reports Second Quarter and First Half 2026 Financial ResultsEvogene reported Q2 2026 net loss of about $1.8 million, down from $4.7 million in Q2 2025, and expects full-year 2026 cash usage of $8.5–9.5 million. The company also expanded its virtual chemical space to about 110 billion molecules and advanced its internal drug discovery program.PR NewswireEvogene Financial Results and Earnings Announcement Schedule for the Full Year and Fourth Quarter of 2021Evogene Ltd., a computational biology company listed on NASDAQ and TASE, announced it will release its financial results for the full year and fourth quarter of 2021 on Thursday, March 10, 2022, with company management hosting a conference call on the same day at 09:00 AM Eastern time. The announcement provides dial-in numbers and webcast access details for investors to participate in the earnings discussion. The article also includes background information on Evogene's three technological engines—MicroBoost AI, ChemPass AI, and GeneRator AI—and its subsidiary portfolio focused on human microbiome therapeutics, medical cannabis, ag-chemicals, and ag-biologicals.Global BankingGrowth of Computational Biology Market: Trends and InsightsThe global computational biology market is projected to reach US$ 12.6 billion by 2027, driven by rising demand for predictive models and increased R&D in drug discovery. Key factors propelling this growth include the high costs of traditional drug development and advancements in bioinformatics research funded by entities like the National Institutes of Health. Major industry players such as Evogene Ltd., Genedata AG, and Chugai Pharmaceutical Co., Ltd. are actively expanding their capabilities through product launches and strategic collaborations.